Policy
See all articles with this subject.
-
CommentWhy the NHS's new ‘Windrush Generation' must get a better deal
Ben Simms on the NHS’s dual role in helping both international recruits and the countries they hail from
-
News
NHS England hired consultancy to find out what it is responsible for
NHS England paid external consultants more than £200,000 to ‘map’ its responsibilities ahead of the merger with NHS Improvement, HSJ has learned.
-
Comment
The NHS needs to talk about productivity
The NHS needs to engage with local industrial strategies to boost booth health and economic sustainability says Michael Wood
-
Expert Briefing
Performance Watch: Lessons from the trial of new A&E targets
Performance Watch is HSJ’ s fortnightly expert briefing on the most pressing performance matters troubling system leaders. Contact me in confidence here .
-
News
Plans to trial sepsis target could be dropped
Plans to trial a new standalone one-hour sepsis target for emergency departments as part of the NHS standards review pilot could be dropped, HSJ understands.
-
News
Investigation of serious safety incidents to be overhauled
The NHS will move away from traditional thresholds for serious incident investigations as part of its new national patient safety strategy.
-
Comment
Cancer waiting times: We need to break the cycle
Dr Fran Woodard on how waiting standards continue to decline as cancer services buckle under pressure
-
News
Safety of health apps to be tested in government 'sandbox'
The regulation of “less than perfectly accurate” health apps is to be overhauled, Matt Hancock’s senior tech advisor has said.
-
News
Data changes “traumatic” but vital, says A&E chief
Moving to new data standards will be “traumatic” for the NHS but is vital because “we are really struggling to measure and understand the activity at the front door of our hospitals,” a senior NHS England figure has said.
-
News
National cancer director will ‘play no part’ in child service decisions
NHS England has said Cally Palmer, national cancer director and chief executive of the Royal Marsden Foundation Trust, will “play no part” in decisions on new child cancer standards.
